Syndicate Bio News Today

Kindly share this postDexude, a leading edtech platform with operations in Nigeria, has announced that it has been awarded the prestigious Business Finland TEMPO funding. This significant funding injection marks a pivotal moment in Dexude’s journey towards transforming education through its AI-powered, live-first, expert-led, and community-driven platform. The Business Finland TEMPO funding is specifically designed […]

Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa BOSTON and ROLLE, Switzerland, April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS , a cloud-native...

Nigerian biotech startup Syndicate Bio has announced a strategic partnership with the National Institute for Cancer Research and Treatment (NICRAT) to initiate the Cancer Genome Nigeria project, a study aimed at bridging cancer disparity gaps by studying the most prevalent cancers across Nigeria's six geopolitical zones and more than 300 ethnolinguistic groups.

In September 2023, 22 African tech startups raised $116.7 million. So far, African startups have raised $2.57 billion in 2023.

Genomics startup 54Gene has initiated the winding down of its operations, sources connected to the company confirmed to TechCabal. The company started the process in July 2023.

Abasi Ene-Obong, former co-founder and CEO of 54gene has launched a new startup, Syndicate Bio.